0000927066-23-000107.txt : 20230512
0000927066-23-000107.hdr.sgml : 20230512
20230512204451
ACCESSION NUMBER: 0000927066-23-000107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230510
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ACKERMAN JOEL
CENTRAL INDEX KEY: 0001220630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 23917958
MAIL ADDRESS:
STREET 1: COVENTRY HEALTH CARE, INC.
STREET 2: 6705 ROCKLEDGE DR SUITE 900
CITY: BETHESDA
STATE: MD
ZIP: 20817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1683938681.xml
FORM 4
X0407
4
2023-05-10
0
0000927066
DAVITA INC.
DVA
0001220630
ACKERMAN JOEL
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
CFO and Treasuer
0
Common Stock
2023-05-10
4
M
0
56306
66.29
A
191097
D
Common Stock
2023-05-10
4
D
0
37059
100.72
D
154038
D
Common Stock
2023-05-10
4
F
0
9826
100.72
D
144212
D
Stock Appreciation Rights
66.29
2023-05-10
4
M
0
56306
0
D
2021-05-15
2023-05-15
Common Stock
56306
0
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
The Stock Appreciation Rights were granted on May 15, 2018, which vested 50% each on May 15, 2021 and May 15, 2022.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2023-05-12